These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16520133)

  • 41. Circadian pattern of ventricular tachycardia episodes in patients with Chagas heart disease.
    Abello M; González-Zuelgaray J; Daglio ME; Lopez C; Garraza S; Szyszko A
    Arq Bras Cardiol; 2007 Feb; 88(2):240-2. PubMed ID: 17384844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.
    Carvalho VO; Ruiz MA; Bocchi EA; Carvalho VO; Guimarães GV
    Cardiol J; 2009; 16(5):426-31. PubMed ID: 19753521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
    Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
    Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of functional and health status measures in heart failure.
    Myers J; Zaheer N; Quaglietti S; Madhavan R; Froelicher V; Heidenreich P
    J Card Fail; 2006 Aug; 12(6):439-45. PubMed ID: 16911910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease.
    Tostes S; Bertulucci Rocha-Rodrigues D; de Araujo Pereira G; Rodrigues V
    Int J Cardiol; 2005 Mar; 99(2):233-7. PubMed ID: 15749181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice.
    Müller-Tasch T; Peters-Klimm F; Schellberg D; Holzapfel N; Barth A; Jünger J; Szecsenyi J; Herzog W
    J Card Fail; 2007 Dec; 13(10):818-24. PubMed ID: 18068614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing responsiveness of generic and specific health related quality of life measures in heart failure.
    Eurich DT; Johnson JA; Reid KJ; Spertus JA
    Health Qual Life Outcomes; 2006 Nov; 4():89. PubMed ID: 17125512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Summary health status measures in advanced heart failure: relationship to clinical variables and outcome.
    Sullivan MD; Levy WC; Russo JE; Crane B; Spertus JA
    J Card Fail; 2007 Sep; 13(7):560-8. PubMed ID: 17826647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chagas' disease and tachycardiomyopathy].
    Brugada P
    Arq Bras Cardiol; 1991 Jan; 56(1):5-7. PubMed ID: 1872709
    [No Abstract]   [Full Text] [Related]  

  • 52. [Systolic and diastolic dysfunction in the indeterminate, digestive and chronic cardiac forms of Chagas' disease].
    Sousa AC; Marin-Neto JA; Maciel BC; Gallo Júnior L; Amorim Dde S; Barreto-Martins LE
    Arq Bras Cardiol; 1988 May; 50(5):293-9. PubMed ID: 3240108
    [No Abstract]   [Full Text] [Related]  

  • 53. Prognostic Factors in Severe Chagasic Heart Failure.
    Costa SA; Rassi S; Freitas EMDM; Gutierrez NDS; Boaventura FM; Sampaio LPDC; Silva JBM
    Arq Bras Cardiol; 2017 Mar; 108(3):246-254. PubMed ID: 28443956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Quality of life and functional status in congestive heart failure].
    Karapolat H; Durmaz B; Nalbantgil S; Durmaz I
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):327-32. PubMed ID: 17162277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of heart failure clinic in the improvement on quality of life of heart failure patients in Mexico.
    Mendez GF; Betancourt L; Galicia-Mora G
    Int J Cardiol; 2007 Feb; 115(2):242-3. PubMed ID: 16766057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bradycardia-tachycardia syndrome in chronic Chagas' cardiopathy].
    Lavadens R; Palmero E
    Arq Bras Cardiol; 1984 May; 42(5):345-50. PubMed ID: 6508592
    [No Abstract]   [Full Text] [Related]  

  • 57. Treating patients with Chagas' cardiomyopathy with chronic heart failure in the contemporary era.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A
    Am Heart J; 2007 Nov; 154(5):e35; author reply e33. PubMed ID: 17967576
    [No Abstract]   [Full Text] [Related]  

  • 58. [Quantification of lymphatic vessels in dilated and chronic chagasic cardiomyopathy].
    Benvenuti LA; Silva AM; Aiello VD
    Arq Bras Cardiol; 2010 Apr; 94(4):564-7. PubMed ID: 20498930
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical aspects of the Chagas' heart disease.
    Punukollu G; Gowda RM; Khan IA; Navarro VS; Vasavada BC
    Int J Cardiol; 2007 Feb; 115(3):279-83. PubMed ID: 16769134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Why is there predominance of right heart failure in Chagas' disease?].
    Marin-Neto JA; Andrade ZA
    Arq Bras Cardiol; 1991 Sep; 57(3):181-3. PubMed ID: 1824192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.